| Research Topics: |
| INDEX |
| AI-chat 3 |
| PRIME 22 |
| aging 3 |
| brain 3 |
| cancer 3 |
| climate 2 |
| cognition 2 |
| covid-19 1 |
| crime 3 |
| culture 3 |
| diabetes 3 |
| diagnostics 2 |
| eyes 2 |
| genetics 1 |
| heart 7 |
| immune 1 |
| microbiome 1 |
| misc 1 |
| nutrition 8 |
| obesity 1 |
| pain 1 |
| practice 1 |
| privacy 2 |
| sleep 1 |
| soc-media |
| tech 2 |
| unk |
| vaccine 1 |
| virus 1 |
| war-cyber 1 |
|
Scanned: 2582 Evaluated: 113 Selected: 37 |
| PRIME CANCER IMMUNE | ||||||||
Sda211-129 | Scientists Supercharge Natural Killer Cells to Fight Aggressive Cancers | |||||||
| Quote: |
In preclinical studies, the enhanced immune cells successfully killed
human cancer cells from several aggressive cancers, including leukemia,
glioblastoma, kidney cancer, and triple-negative breast cancer. The
treatment approach also significantly slowed tumor growth in animal
models....
The study, "PTPN1/PTPN2 inhibition improves NK cancer therapy by enhancing IL-2 and mitigating TGF #120515;1 response" by Chu-Han Feng et al. and Michel L. Tremblay, was published in EMBO Reports in April 2026. | |||||||
| Article: | https://www.sciencedaily.com/releases/2026/05/260523103910.htm | |||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||
| Search Authors: | Chu-Han Feng et al. and Michel L. Tremblay, | |||||||
|
Javilk's Research Links for Week 21 Updated 05/30/2026-01:22:31 AM What interests you? What have you found? Tell me! Drop me a note to subscribe or submit something. |